Evaluation of Diprospan Injection to the Knee on Rehabilitation of Patients After TKR of the Contralateral Knee
Status:
Completed
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
This study is performed to assess the influence of intraarticular injection of 2ml Diprospan
(wich contains 4mg Betamethasone sodium phosphate and 10mg Betamethasone dipropionate) into
osteoarthritic knee in patients who undergo a total knee replacement of their contralateral
knee.
The study population will include 50 patients with bilateral knee osteoarthritis, admitted
for their first knee replacement surgery. Only patients with older than 50 years with primary
osteoarthritis will be included. The patients will be randomized into 2 groups. Intervention
group will receive an injection of 2ml Diprospan diluted in 10 ml Bupivocaine. The control
group will receive an injection of 10ml of Bupivocaine. All patients will be followed after 6
weeks and three functional rehabilitation and pain scores will be assessed (VAS pain score,
Timed Up and Go Score and Functional Ambulatory Category Scale).